tiprankstipranks
The Valens (TSE:VLNS)
TSX:VLNS

The Valens Stock Price & Analysis

81 Followers

VLNS Stock Chart & Stats

Day’s RangeC$0 - C$0
52-Week Range― - ―
Previous CloseC$0.92
Volume60.75K
Average Volume (3M)154.16K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)C$19.05M
Total Debt (Recent Filing)C$5.08M
P/E Ratio-0.3
Beta2.48
Next EarningsOct 19, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)-3.08
Shares Outstanding80,621,300
R-Squared0.12
Standard Deviation0.20
10 Day Avg. Volume119,512
30 Day Avg. Volume154,160
P/B Ratio0.85
P/S Ratio1.13
P/CF Ratio1352.40
P/FCF Ratio-1.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/EbitdaN/A
Price Target Upside89.26% Upside
Rating ConsensusModerate Buy
Alpha-0.05
Number of Analyst Covering5


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

VLNS FAQ

What was The Valens’s price range in the past 12 months?
Currently, no data Available
What is The Valens’s market cap?
Currently, no data Available
When is The Valens’s upcoming earnings report date?
The Valens’s upcoming earnings report date is Oct 19, 2022 which is in 23 days.
    How were The Valens’s earnings last quarter?
    The Valens released its earnings results on Jul 13, 2022. The company reported -C$2.13 earnings per share for the quarter, missing the consensus estimate of -C$0.185 by -C$1.945.
      Is The Valens overvalued?
      According to Wall Street analysts The Valens’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does The Valens pay dividends?
        The Valens does not currently pay dividends.
        What is The Valens’s EPS estimate?
        The Valens’s EPS estimate is -C$0.17.
          How many shares outstanding does The Valens have?
          The Valens has 80,621,300 shares outstanding.
            What happened to The Valens’s price movement after its last earnings report?
            The Valens reported an EPS of -C$2.13 in its last earnings report, missing expectations of -C$0.185. Following the earnings report the stock price went up 4.494%.
              Which hedge fund is a major shareholder of The Valens?
              Currently, no hedge funds are holding shares in TSE:VLNS

              ---

              The Valens Stock Analysis

              Smart ScoreUnderperform
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10
              3
              The The Valens stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
              Learn more about TipRanks Smart Score

              Company Description

              The Valens

              Valens GroWorks Corp. is a biotechnology company. It is engaged in the provision of cannabis products developed from the firm's proprietary extraction techniques. The firm also offers management, consulting, testing, and support services to domestic and international licensees, as well as financing and managing the build out of fully-licensed third party operations. The company was founded on January 14, 1981 and is headquartered in Kelowna, Canada.

              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              SNDL

              Popular Stocks

              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis